Valuation: Baxter International Inc.

Capitalization 9.1B 7.85B 7.08B 6.8B 12.39B 836B 12.97B 83.74B 33.55B 401B 34.16B 33.43B 1,435B P/E ratio 2026 *
29.3x
P/E ratio 2027 * 19.9x
Enterprise value 15.59B 13.44B 12.13B 11.64B 21.23B 1,433B 22.22B 143B 57.46B 687B 58.5B 57.26B 2,457B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.29x
Free-Float
74.36%
Yield 2026 *
0.22%
Yield 2027 * 0.24%
1 day-4.89%
1 week-13.16%
Current month-13.16%
1 month-18.59%
3 months-4.58%
6 months-27.56%
Current year-7.43%
1 week 17.54
Extreme 17.535
19.97
1 month 17.54
Extreme 17.535
22.41
Current year 17.54
Extreme 17.535
22.41
1 year 17.4
Extreme 17.4
37.74
3 years 17.4
Extreme 17.4
50.21
5 years 17.4
Extreme 17.4
89.7
10 years 17.4
Extreme 17.4
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Director of Finance/CFO 56 18/10/2023
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 75 06/02/2017
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
-4.89%-13.16%-51.63%-54.63% 9.1B
-1.33%-5.84%-20.11%+9.58% 190B
-2.27%-6.92%-3.81%+14.00% 117B
-0.23%-3.68%+40.80%+133.97% 69.73B
+1.31%+0.87%+64.51%+103.21% 60.92B
-1.66%-5.30%-27.19%-29.23% 47.59B
-0.50%-7.75% - - 35.57B
-3.66%-7.26%-12.51%-40.16% 26.21B
-3.35%-8.65%-0.96%+26.87% 22.61B
+4.33%-2.32%-23.13%+13.46% 19.29B
Average -1.22%-5.77%-3.78%+19.67% 59.81B
Weighted average by Cap. -1.14%-5.27%-0.10%+30.24%

Financials

2026 *2027 *
Net sales 11.35B 9.79B 8.84B 8.48B 15.46B 1,043B 16.18B 104B 41.85B 500B 42.61B 41.7B 1,789B 11.6B 10B 9.03B 8.66B 15.79B 1,066B 16.53B 107B 42.75B 511B 43.53B 42.6B 1,828B
Net income 360M 310M 280M 269M 490M 33.08B 513M 3.31B 1.33B 15.87B 1.35B 1.32B 56.74B 483M 416M 376M 360M 657M 44.35B 688M 4.44B 1.78B 21.27B 1.81B 1.77B 76.07B
Net Debt 6.49B 5.59B 5.05B 4.84B 8.83B 596B 9.24B 59.68B 23.91B 286B 24.34B 23.83B 1,022B 5.81B 5.01B 4.52B 4.34B 7.91B 534B 8.28B 53.44B 21.41B 256B 21.8B 21.33B 915B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
06/03/26 17.69 $ -4.89% 10,709,787
05/03/26 18.60 $ -2.26% 10,856,292
04/03/26 19.03 $ 0.00% 8,653,038
03/03/26 19.03 $ -3.35% 9,039,603
02/03/26 19.69 $ -3.34% 7,287,906
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
17.69USD
Average target price
21.63USD
Spread / Average Target
+22.29%

Quarterly revenue - Rate of surprise